NCT00440154View on ClinicalTrials.gov

A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia

PHASE2CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Hypercholesterolemia
Interventions
DRUG

AVE5530

DRUG

placebo

DRUG

ezetimibe

Trial Locations (6)

Unknown

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Seoul

Sanofi-Aventis Administrative Office, Istanbul

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00440154 - A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia | Biotech Hunter | Biotech Hunter